Form D · Biotechnology
Azure Health Technology Ltd
Sydney, C3 · CIK 0001817595
Offering snapshot reported Jul 24, 2020 · SEC filing
- Reported sold
- $353K Offering amount: $353K
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 11, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 24, 2020 | Initial | $352,766 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-371750
Source: Form D, filed Jul 24, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrew David Bristow | Director |
| Catriona Betty Glover | Executive |
| Louis James Panaccio | Director |
| Gregory Barry Starr | Director |
| Glenn Tong | Director |
| Jiayi Yu | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
C/O Mlc Centre, Suite 03, Level 45 19 29 Martin Place
Sydney, C3, 2000
Sydney, C3, 2000